• Citer

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.

par Rabaglio, M;Sun, Z;Price, K;Castiglione-Gertsch, Monica;Hawle, H;Thürlimann, Beat;Mouridsen, Henning;Campone, M.;Forbes, John F;Paridaens, R J;Colleoni, Marco Angelo;Pienkowski, Tadeusz;Nogaret, Jean-Marie ;Láng, I;Smith, Ian;Gelber, R D;Goldhirsch, Aron;Coates, Alan;BIG 1-98 Collaborative and International Breast Cancer Study Groups,
Référence Annals of oncology, 20, 9, page (1489-1498)
Publication Publié, 2009-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
Auteur:	Rabaglio, M; Sun, Z; Price, K; Castiglione-Gertsch, Monica; Hawle, H; Thürlimann, Beat; Mouridsen, Henning; Campone, M.; Forbes, John F; Paridaens, R J; Colleoni, Marco Angelo; Pienkowski, Tadeusz; Nogaret, Jean-Marie; Láng, I; Smith, Ian; Gelber, R D; Goldhirsch, Aron; Coates, Alan; BIG 1-98 Collaborative and International Breast Cancer Study Groups,
Informations sur la publication:	Annals of oncology, 20, 9, page (1489-1498)
Statut de publication:	Publié, 2009-09
Sujet CREF:	Cancérologie
MeSH keywords:	Aged
	Antineoplastic Agents -- therapeutic use
	Breast Neoplasms -- complications -- drug therapy
	Double-Blind Method
	Female
	Fractures, Bone -- epidemiology -- etiology
	Humans
	Incidence
	Middle Aged
	Nitriles -- therapeutic use
	Postmenopause
	Risk Factors
	Tamoxifen -- therapeutic use
	Triazoles -- therapeutic use
Note générale:	Clinical Trial, Phase III
	Journal Article
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1093/annonc/mdp033
	info:pii/mdp033
	info:scp/69849115729
	info:pmid/19474112
	PMC2731016